| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |